Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
-
Search results from the "OB_Rx" table for query
on "202022."
| Active Ingredient: | RILPIVIRINE HYDROCHLORIDE |
| Dosage Form;Route: | TABLET; ORAL |
| Proprietary Name: | EDURANT |
| Applicant: | JANSSEN PRODS |
| Strength: | EQ 25MG BASE |
| Application Number: | N202022 |
| Product Number: | 001 |
| Approval Date: | May 20, 2011 |
| Reference Listed Drug | Yes |
| RX/OTC/DISCN: | RX |
| TE Code: | |
| Patent and Exclusivity Info for this product: | View |
|
|
|
Return to Electronic Orange Book Home Page
| FDA/Center for Drug Evaluation and Research |
| Office of Generic Drugs |
| Division of Labeling and Program Support |
| Update Frequency: |
| Orange Book Data - Monthly |
| Generic Drug Product Information & Patent Information - Daily |
| Orange Book Data Updated Through May, 2013 |
| Patent and Generic Drug Product Data Last Updated: June 18, 2013 |
-
